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Abstract
Matrix Metalloproteinase-2 (Mmp2) is a collagenase known to be important in the develop-
ment of renal fibrosis. In unilateral ureteral obstruction (UUO) the obstructed kidney (OK)
develops fibrosis, while the contralateral (CL) does not. In this study we investigated the
effect of UUO on gene expression, fibrosis and pelvic remodeling in the kidneys of Mmp2
deficient mice (Mmp2-/-), heterozygous animals (Mmp2+/-) and wild-type mice (Mmp2+/+).
Sham operated animals served as controls (Cntrl). UUO was prepared under isoflurane
anaesthesia, and the animals were sacrificed after one week. UUO caused hydronephrosis,
dilation of renal tubules, loss of parenchymal thickness, and fibrosis. Damage was most
severe in Mmp2+/+ mice, while both Mmp2-/- and Mmp2+/- groups showed considerably
milder hydronephrosis, no tubular necrosis, and less tubular dilation. Picrosirius red quantifi-
cation of fibrous collagen showed 1.63±0.25% positivity in OK and 0.29±0.11% in CL
(p<0.05) of Mmp2+/+, Mmp2-/- OK and Mmp2-/- CL exhibited only 0.49±0.09% and 0.23
±0.04% (p<0.05) positivity, respectively. Mmp2+/- OK and Mmp2+/- CL showed 0.43
±0.09% and 0.22±0.06% (p<0.05) positivity, respectively. Transcriptomic analysis showed
that 26 genes (out of 48 examined) were differentially expressed by ANOVA (p<0.05). 25
genes were upregulated in Mmp2+/+ OK compared to Mmp2+/+ CL: Adamts1, -2, Col1a1,
-2, -3a1, -4a1, -5a1, -5a2, Dcn, Fbln1, -5, Fmod, Fn1, Itga2, Loxl1, Mgp, Mmp2, -3, Nid1,
Pdgfb, Spp1, Tgfb1, Timp2, Trf, Vim. In Mmp2-/- and Mmp2+/- 18 and 12 genes were
expressed differentially between OK and CL, respectively. Only Mmp2 was differentially
regulated when comparing Mmp2-/- OK and Mmp2+/- OK. Under stress, it appears that
Mmp2+/- OK responds with less Mmp2 upregulation than Mmp2+/+ OK, suggesting that
there is a threshold level of Mmp2 necessary for damage and fibrosis to occur. In
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conclusion, reduced Mmp2 expression during UUO protects mice against hydronephrosis
and renal fibrosis.
Introduction
Obstructive nephropathy is a common cause of kidney damage and renal insufficiency, both in
congenital obstructive nephropathy in children [1], and acquired obstruction caused by kidney
stones, malignancies and benign prostate hyperplasia [2]. In rodents unilateral ureteral
obstruction (UUO) is a well-studied model that leads to hydronephrosis with tubular dilation,
cortical atrophy and fibrosis. UUO is interesting both as a model of ureteral obstruction, and
for studying the fibrotic process as such [3]. The development and degree of fibrosis is consid-
ered to be one of the most reliable prognostic markers for loss of kidney function and progres-
sion towards end stage renal disease (ESRD) [4].
Matrix Metalloproteinase-2 (Mmp2), also known as gelatinase-A, is a 72 kDa collagenase
that is important in extracellular matrix metabolism. Mmp2 cleaves type IV collagen, and
degrades already denatured collagens [5]. In the kidney, Mmp2 is upregulated in several patho-
logical states [6–9]. Inhibition of Mmp2 activity results in disparate outcomes depending on
the phase of kidney disease studied and on the underlying cause [10,11]. For example, it has
been shown that Mmp2 facilitates fibrosis by participating in epithelial to mesenchymal transi-
tion [12]. Mmp2 has also been found to be involved in tubular repair after acute kidney injury
(AKI) [13], and Mmp2 deficiency protects against ischemia-reperfusion AKI [14].
Mmp2 knockout mice (Mmp2-/-) do not show major anatomical abnormalities, but are
born smaller and grow more slowly than the wild type (Mmp2+/+), suggesting that Mmp2 is
important for fetal development and growth [15]. Knockout of the Mmp2 gene occurs in exon
1, resulting in no Mmp2 expression neither at the RNA nor the protein level [15]. The
Mmp2-/- mice show reduced angiogenic response in oxygen-induced retinopathy [16], and are
more susceptible to diabetic nephropathy [17]. However, they are protected against haemor-
rhagic transformation during the early stages of cerebral ischemia and reperfusion [18].
Since UUO damage is closely connected to the remodeling of the renal pelvis and the defor-
mation of the kidney parenchyma, we hypothesized that Mmp2-deficiency would protect the
obstructed kidney (OK). However, a recent study of pharmacological inhibition in the UUO
model showed increased fibrosis, while cellular infiltration was decreased [19]. The aim of the
present study was to investigate the effect of homozygous and heterozygous genetic inactiva-
tion of Mmp2 on gene expression, fibrosis and pelvic remodeling in the kidneys of mice after
one week of UUO.
The fibrotic process was investigated in knockout animals (Mmp2-/-), heterozygotes
(Mmp2+/-) and wild-type C57Black6J (Mmp2+/+) mice. In addition, sham operated individu-
als from each group served as controls (Cntrl-/-, Cntrl+/-, Cntrl+/+). The genes selected for
investigation in this study were chosen due to their involvement in fibrosis and renal damage.
Materials and Methods
Animals
Mmp2 deficient C57BL/6J mice were generously provided by Dr. Werb [15] at Inserm UMR
702, Université Pierre et Marie Curie, Paris, and later transferred to Bergen for use in the pres-
ent project. The animals were kept and bred at the animal facility at the Department of Bio-
medicine in Bergen. The study consisted of 6 groups; Mmp2+/+ Control (Cntrl+/+) (n = 10)
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and UUO (n = 10), Mmp2+/- Control (Cntrl+/-) (n = 10) and UUO (n = 11), and Mmp2-/-
Control (Cntrl-/-) (n = 10) and UUO (n = 9) (Table 1). The control groups were sham
operated.
Ethics Statement
The experiments were conducted in accordance with the guidelines of, and with approval
obtained from the Norwegian State Board for Biological Experiments with Living Animals
(Approval No: 2009–1899). All surgery was carried out under isoflurane anaesthesia.
Ureteral obstruction
UUO was prepared under isoflurane anaesthesia. The left ureter was identified through a sub-
costal incision, and obstructed using a silk ligature at the level of the lower pole of the kidney.
The animals were sacrificed under isoflurane anaesthesia one week after obstruction. The
abdominal aorta was dissected and cannulated in order to perfuse the animal with ice-cold PBS
before the kidneys were removed. The kidneys were cut in transverse slices that were either sta-
bilised in RNA-later, or fixed in 4% formaldehyde, processed and embedded in paraffin.
Histology
Morphological damage was investigated by light microscopy using 3 μm sections, stained with
Periodic Acid-Schiff (PAS). In order to monitor the amount of collagen in the different experi-
mental groups, 7 μm sections were stained with Picrosirius Red and examined according to our
previously published protocol [9]. Briefly, digital images were captured randomly under con-
stant polarized light in a Leica DMLB microscope connected to a CCD ColorView IIIu camera.
Image acquisition and analysis was performed using CellD version 2.4. Intensity was separated
as a gray-scale image from the HSI colour-space. The detection threshold was the same for all
images. Collagen content was expressed as percent positive pixels of total pixels.
Quantitative RTPCR
RNA was extracted from the kidneys using an RNeasy mini kit (Qiagen, West Sussex, UK) as
described in the protocol provided by the manufacturer, and cDNA was synthesised from
RNA using Reverse Transcriptase Core Kit obtained from Eurogentec (Seraing, Belgium). A
custom-made Low Density Array (LDA) from Applied Biosystems was used to determine the
mRNA expression levels of a selection of genes. The method is based on the well-established
quantitative RT-PCR (QRT-PCR) technique, however, LDA has the benefit of enabling quanti-
fication of several genes simultaneously and at the same time maintaining the sensitivity of
QRT-PCR [20]. 18s ribosomal RNA was used as a standard. In addition Gapdh, Tbp, Pgk1 and
Ppia were used as housekeeping genes.
Statistical analysis
Data is presented as means ± standard error of the mean (SEM), except for comparison of the
expression of individual genes where the fold-change is used. The probability of chance differ-
ence was tested using ANOVA, with Fisher’s test and à priori contrasts to test individual com-
parisons. Comparisons between CL and OK were paired. The Bonferroni correction was used
for gene-expression data, separately across samples and across genes for each comparison
made. P< 0.05 was accepted as statistically significant.
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Results
Kidney damage in UUO
A total of 60 mice were used in the UUO experiment (Table 1). UUO caused severe hydrone-
phrosis in Mmp2+/+, which was accompanied by tubular dilation, necrosis and atrophy, while
Mmp2-/- and Mmp2+/- showed considerably milder hydronephrosis, no tubular necrosis, and
less tubular dilation (Figs 1 and 2). Automatic image analysis of collagen content in Picrosirius
Red stained sections showed 1.63±0.25% positivity in OK and 0.29±0.11% in CL (p<<0.05) of
Mmp2+/+, whereas Mmp2-/- OK and Mmp2-/- CL only showed 0.49±0.09% and 0.23±0.04%
(p<0.05) positivity, respectively, and Mmp2+/- OK and Mmp2+/- CL exhibited 0.43±0.09%
and 0.22±0.06% (p<0.05) positivity, respectively (Figs 3 and 4). There were no significant dis-
crepancies between the levels of fibrosis in the control kidneys and the CL kidneys in any of the
groups.
Gene expression
Using RTPCR, 26 out of 48 genes examined showed differential expression when ANOVA was
applied across groups (Table 2). None of the housekeeping genes showed significant changes,
and the results were comparable when using the different genes for normalisation. Data are
presented using 18S as standard. There was no difference in gene expression between CL and
control kidneys in any of the groups.
The greatest difference in gene expressions was seen when comparing the OK and CL in the
Mmp2+/+ mice, where 25 genes were significantly altered (Table 2). A comparison of
Mmp2-/- OK vs Mmp2-/- CL identified 18 significantly altered genes. Mmp2+/- OK displayed
12 significantly altered genes when compared to Mmp2+/- CL. Cntrl+/- did not differ from
Cntrl+/+ in any of the 48 tested genes. After UUO, Mmp2 expression was 7-fold and 5.5-fold
induced in Mmp2+/+ OK and Mmp2+/- OK, respectively, when compared to Mmp2-/- OK.
Comparisons between Mmp2-/- OK vs Mmp2-/- CL, and Mmp2+/- OK vs Mmp2+/- CL
showed that five genes in common did not respond in the same manner as in the Mmp2
+/+ OK vs Mmp2+/+ CL comparison. These genes are Loxl1, Fbln5, Fmod, Fbln1 and Col5a2.
None of these genes were significantly altered after UUO in Mmp2 -/- and Mmp2+/- mice. In
contrast, all five genes were upregulated in Mmp2+/+ mice. Fmod is downregulated in both
Mmp2-/- and Mmp2+/- OK groups compared to Mmp2+/+ OK. Mmp9 showed a 2.2-fold
upregulation in Mmp2-/- OK when compared to Mmp2-/- CL mice. Only Mmp2 was differen-
tially regulated when comparing Mmp2-/- OK and Mmp2+/- OK. In addition to the house-
keeping genes, 17 genes were not differentially expressed between any of the groups.
Discussion
The present study demonstrates that Mmp2-/- and Mmp2+/- mice display less pelvic-remodel-
ling and fibrosis compared to Mmp2+/+ mice after UUO. Both Mmp2-/- and Mmp2+/- mice
Table 1. Bodyweight and age of the mice at the start of the experiment.
Mmp2+/+ Mmp2+/- Mmp2-/-
Control UUO Control UUO Control UUO
n = 10 10 10 11 10 9
Bodyweight (g) 31±0.4 23±0.3 35±1 38±2 29±2 29±2
Age (weeks) 14±0 9±0 19±1 37±2 20±2 41±6
doi:10.1371/journal.pone.0143390.t001
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are protected, which may indicate an important effect of gene-dose. Furthermore, Mmp2
+/+ mice displayed more histological damage and showed the highest response in gene expres-
sion following UUO, with 25 genes significantly altered when comparing OK to CL. Both
Mmp2-/- and Mmp2+/- animals gave a milder response to UUO, showing 18 and 12 signifi-
cantly altered genes after UUO, respectively. The main findings in this study are similar to
those of Du et al., described in a comprehensive paper in which they also reported reduced
infiltration of immune cells, and improved immunohistochemistry for a number of collagens
and renal injury markers [21]. Our RT-PCR results correlate to those of Du et al with similar
expression patterns for Mmp2, Mmp9, Timp1 and Timp2. However, our study presents a
wider range of molecular markers, and also data from heterozygotes beyond what has been pre-
viously reported.
Fig 1. Representative images of Period Acid-Schiff (PAS) stained transversal sections showing
increasedmorphological damage in the Mmp2+/+ obstructed kidney (OK, 1B) compared to the other
groups (1 D, F). The Mmp2+/+ OK (1B) shows severe hydronephrosis and inflammation of the renal pelvis,
while the Mmp2-/- OK (1F) and Mmp2+/- OK (1D) only display slight dilatation and minimal inflammation. The
contralateral kidneys (CL, 1 A, C, E) do not differ from each other and show normal morphology.
doi:10.1371/journal.pone.0143390.g001
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When comparing the control kidneys between the groups, the lack of Mmp2 does not seem
to affect the amount of collagen when the kidney is not under stress (Fig 4). As expected, the
level of Mmp2 in both Cntrl+/- and Cntrl+/+ animals is higher relative to the Cntrl-/- group.
There is no significant difference in Mmp2 expression between wild type and heterozygotes
under control conditions. Mmp2 gene expression in Mmp2+/- mice is not upregulated in OK
as much as in the Mmp2+/+ OK. This could suggest that there is a threshold level of Mmp2
necessary for damage and fibrosis to occur and this level might not be reached in the Mmp2+/-
mice, thus resulting in protection of the kidneys in Mmp2+/- mice as well. Taken together with
the fact that Mmp2 upregulation is required for regulation of several of the genes studied here,
this could point towards a cascade effect where a threshold level of Mmp2 is important for ini-
tiation of fibrogenesis.
Fig 2. Morphological damage in the obstructed kidney (OK, 2B, D, F) compared to the contralateral
kidney (CL, 2 A, C, E). All OK kidneys show tubular dilatation, flattened tubular epithelium with loss of brush
border and reactive nuclear enlargement. Only Mmp2+/+ OK (2B) shows necrotic tubules (asterix) and many
apoptotic cells (arrows). The morphology of the CL kidney is normal. (PAS stain).
doi:10.1371/journal.pone.0143390.g002
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Some of the genes utilised in our study have been investigated previously in similar settings,
and could help elucidate the role of Mmp2 after UUO. The effect of pharmacological inhibition
of Mmp2 seems to be dependent on the time of administration in UUO-induced renal fibrosis.
Late administration of an inhibitor of Mmp2, TISAM, decreased the level of macrophage infil-
tration, while early administration did not, and contrary to our findings both early and late
inhibition of Mmp2 resulted in accelerated fibrosis in the mouse kidney [19]. Inhibition by
He4, an Mmp2/Mmp9 inhibitor and a pan-serine protease which has been shown to directly
interact with and inhibit Mmp2 and Mmp9, improved the outcome after UUO [22]. He4-inhi-
bition, and thus an increase in Mmp2 and Mmp9 mediated collagen I digestion, resulted in less
fibrosis compared to the control group. Taken together, this suggests that genetic deficiency of
Mmp2 affects the development of fibrosis by a different mechanism than pharmacological
inhibition of Mmp2. This time dependency has also been described in a mouse model of Alport
Fig 3. Representative images of Picrosirius Red stained sections under polarised light from the
obstructed kidney (OK, 3 B, D, F) compared to the contralateral kidney (CL, 3 A, C, E). There is a higher
level of collagen in Mmp2+/+ OK (3 B) compared to OK in both Mmp2+/- and Mmp2-/- (3 D, F). Only minimal
levels of collagen are detected in CL kidneys across all groups (3 A, C, E).
doi:10.1371/journal.pone.0143390.g003
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syndrome [10]. Early combination therapy with inhibitors of Mmp2, Mmp3 and Mmp9 signif-
icantly delayed the onset of proteinuria, while treatment after onset of proteinuria accelerated
renal disease.
In addition, Mmp2 has been shown to affect vascular reactivity. For example endothelin-1
requires cleavage to produce the active hormone and Mmp2 contributes to this process [23].
Mmp2 has also been found to cleave adrenomedullin, resulting in production of a vasocon-
strictor peptide [24], and this may be an underlying mechanism that leads to kidney damage
[25]. One may suggest that Mmp2 deficiency decreases vasoconstriction and thus reduces kid-
ney damage in UUO.
Mmp9 deficiency seems to have a positive effect during UUO [26], while pharmacological
inhibition of Mmp9 has a time-dependent effect, with reduced epithelial to mesenchymal tran-
sition and fibrosis at the early or chronic stage, but not during the establishment of fibrosis
[11]. The present data show upregulation of Mmp9 in the obstructed kidney in Mmp2-/- mice
compared to CL, which may be a compensatory increase due to the lack of Mmp2 [10]. How-
ever, Mmp9 was not upregulated after UUO in Mmp2+/- animals, and since both strains
showed less damage, it is unlikely that Mmp9 alone is responsible for the decreased fibrosis
after UUO.
Decorin (Dcn) deficient mice have been reported to show greater damage than WT after
UUO [27]. This could indicate that an upregulation of Dcn is a protective mechanism. How-
ever, while the expression of Dcn mRNA was increased after UUO in wild type and knockout
mice, there was no effect in heterozygous animals. These results, therefore, do not allow one to
draw firm conclusions regarding the potential protective role of Dcn. Timp2 is not differen-
tially expressed between the groups, yet there is an upregulation of Timp2 in the OK kidney
compared to the CL kidney in both Mmp2+/+ and Mmp2-/- mice, but not in the Mmp2+/-
group. However, we do not have any basis to explain why Mmp2+/- mice regulate Timp2 dif-
ferently under the stress of UUO. Earlier data showed that Timp2 promotes injury through
activating Mmp2 [28]. In both Mmp2-/- and Mmp2+/- animals Timp2 has less Mmp2 to acti-
vate, which could be a mechanism behind the reduced rate of fibrosis and remodelling. Thus,
Fig 4. Image analysis of collagen in Picrosirius Red stained sections under polarised light. Collagen
content is expressed as the percent of positive pixels to all pixels. * denotes P<0.05 compared to the
contralateral kidney (CL). # denotes P<0.05 compared to OK in Mmp2+/+.
doi:10.1371/journal.pone.0143390.g004
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Table 2. Differential gene expression between strains (Mmp2 +/+, +/-, and -/-), and as paired comparisons between the obstructed (OK) and contra-
lateral kidneys (CL) of the same animal.
Gene Average OK-/- OK-/- OK+/- OK-/- CL-/- OK+/- CL+/- OK+/+ CL+/+ Cntrl-/- Cntrl-/- Cntrl+/-
CT-value vs vs vs vs vs vs vs vs vs vs vs vs
± SEM OK+/+ OK+/- OK+/+ CL-/- Cntrl-/- CL+/- Cntrl+/- CL+/+ Cntrl+/+ Cntrl+/+ Cntrl+/- Cntrl+/+
Mmp2 † 33.05 ± 0.28 -7.060 * -5.774 * -1.287 * -0.907 0.704 3.973 * -0.345 4.079 * 0.455 -2.323 * -1.942 * -0.381
Adamts2 † 31.06 ± 0.22 -0.666 0.479 -1.146 * 2.748 * 0.532 3.122 * 0.247 3.867 * 0.033 -0.046 0.569 -0.615
Dcn † 28.22 ± 0.18 -0.533 0.534 -1.067 * 1.774 * 0.914 1.269 0.801 3.078 * -0.567 -0.710 -0.084 -0.626
Mgp † 24.65 ± 0.32 0.829 0.421 0.408 2.853 * 1.599 3.673 * 0.420 3.555 * -0.152 -0.219 0.062 -0.280
Adamts1 † 29.84 ± 0.24 0.726 0.435 0.291 3.840 * -0.241 3.591 * -0.626 2.463 * -0.012 -0.423 -0.199 -0.224
Spp1 † 23.72 ± 0.28 0.870 0.483 0.387 3.409 * 1.432 4.996 * -0.538 3.337 * 0.887 0.255 0.100 0.154
Col4a1 † 25.82 ± 0.16 -0.187 0.340 -0.527 2.463 * 0.071 0.977 1.208 2.160 * 0.349 -0.212 -0.009 -0.203
Fn1 † 29.61 ± 0.25 -0.782 0.149 -0.930 1.713 1.742 4.074 * -0.643 4.371 * 0.295 0.429 0.125 0.304
Col1a2 † 26.48 ± 0.23 -0.845 0.475 -1.320 3.921 * -0.011 3.598 * -0.133 4.415 * 0.123 -0.217 0.029 -0.246
Vim † 27.38 ± 0.17 -0.369 0.403 -0.772 2.109 * 0.633 1.032 1.342 3.098 * 0.065 0.051 0.034 0.016
Nid1 † 29.28 ± 0.15 -0.358 0.132 -0.490 1.578 * 0.620 1.296 * 0.774 1.898 * 0.764 0.106 0.004 0.103
Mmp3 † 32.99 ± 0.29 0.052 0.600 -0.548 4.706 * 0.870 4.741 * -0.138 4.228 * 0.029 -1.267 -0.374 -0.893
Trf † 30.29 ± 0.23 0.461 0.530 -0.069 1.550 * 0.221 1.201 0.656 2.591 * 0.025 1.305 0.616 0.689
Col3a1 † 28.04 ± 0.31 -0.610 0.958 -1.568 5.332 * 0.239 4.743 * -0.003 5.177 * 0.561 -0.444 0.126 -0.570
Col1a1 † 29.56 ± 0.21 -0.953 0.671 -1.624 4.894 * 0.349 4.655 * -0.306 4.914 * 0.534 -0.747 -0.223 -0.524
Loxl1 † 29.77 ± 0.18 -0.088 0.172 -0.261 1.518 1.255 1.147 1.518 2.978 * -0.067 0.049 0.064 -0.014
Tgfb1 † 28.97 ± 0.16 0.316 0.329 -0.014 2.336 * 0.309 0.983 1.514 2.450 * -0.003 0.118 0.181 -0.063
Col5a1 † 32.47 ± 0.23 -1.296 0.050 -1.346 1.573 1.698 2.074 * 1.065 3.823 * 1.038 0.293 -0.082 0.376
Pdgfb † 29.29 ± 0.22 0.640 0.237 0.404 1.701 * 0.897 1.189 1.077 1.682 * 0.191 -0.085 -0.094 0.010
Fbln5 † 28.53 ± 0.14 -0.462 -0.029 -0.433 0.824 0.238 0.905 -0.134 1.575 * 0.136 0.186 -0.321 0.507
Fmod † 31.42 ± 0.10 -1.316 * -0.260 -1.057 * 0.309 0.057 0.768 -0.384 1.217 * -0.284 -0.750 -0.242 -0.508
Mmp9 † 34.56 ± 0.24 0.568 0.864 -0.296 2.160 * 1.186 0.967 2.494 5.068 -2.000 0.289 0.980 -0.690
Fbln1 † 30.71 ± 0.17 0.374 0.763 -0.389 1.666 1.588 1.223 1.119 2.411 * -0.161 -0.629 -0.148 -0.481
Timp2 † 29.50 ± 0.13 0.319 0.488 -0.169 1.455 * 0.797 0.952 0.885 1.424 * 0.308 -0.201 0.072 -0.274
Col5a2 † 30.88 ± 0.18 -0.571 0.346 -0.917 1.280 1.092 0.856 1.236 2.922 * -0.026 -0.048 0.065 -0.114
Itga2 † 34.10 ± 0.25 -0.603 0.568 -1.171 3.203 * 0.285 2.148 -0.567 3.516 * -0.231 -0.807 -1.340 0.532
Lgals3 27.31 ± 0.20 -0.079 0.289 -0.368 1.423 0.684 0.699 1.264 2.212 -0.271 -0.245 0.144 -0.389
Timp1 31.18 ± 0.42 -0.642 0.328 -0.970 3.155 4.151 3.867 3.489 7.435 -0.743 -1.256 0.378 -1.634
Itgb3 33.51 ± 0.22 -0.273 0.262 -0.534 1.860 0.322 0.406 1.516 2.377 0.911 0.833 0.002 0.831
Pdgfa 31.10 ± 0.14 0.383 0.366 0.017 0.975 0.782 0.815 0.511 1.418 -0.204 -0.159 -0.064 -0.095
Il1b 32.40 ± 0.19 -0.147 0.259 -0.406 1.526 1.701 1.332 1.269 3.335 -0.494 -0.533 -0.368 -0.166
Pgk1 26.20 ± 0.12 0.040 -0.164 0.204 -0.438 -0.175 0.007 -0.611 -0.886 -0.002 -0.235 -0.155 -0.080
Itgav 27.80 ± 0.19 0.081 -0.048 0.129 0.953 0.236 0.942 0.410 1.513 -0.128 0.277 0.115 0.162
Vegfa 27.77 ± 0.08 -0.238 -0.073 -0.165 -0.459 -0.148 -0.196 -0.469 -0.769 0.295 -0.104 -0.131 0.027
Gapdh 22.53 ± 0.21 -0.034 -0.031 -0.003 -0.162 -0.205 0.033 -0.434 -0.439 -0.202 -0.308 -0.065 -0.243
Vegfc 32.97 ± 0.11 0.159 0.458 -0.299 0.649 0.427 0.557 -0.275 0.766 -0.072 -0.224 -0.337 0.113
Nkap 30.48 ± 0.09 0.329 0.132 0.197 0.557 0.061 0.628 -0.052 0.247 -0.090 -0.132 0.089 -0.221
Itga10 34.71 ± 0.12 0.009 0.341 -0.331 0.506 -0.373 0.308 -0.190 1.233 -0.230 0.880 0.326 0.554
Vegfb 29.01 ± 0.12 0.489 0.056 0.434 -0.465 0.116 -0.082 -0.249 -0.814 0.074 0.098 0.074 0.024
Itga11 34.60 ± 0.16 -0.295 0.767 -1.062 1.445 0.832 1.340 0.034 2.641 -0.138 -0.069 -0.136 0.067
Pdgfc 30.78 ± 0.11 0.203 0.140 0.063 -0.036 -0.123 0.309 -0.418 -0.412 0.191 0.140 0.190 -0.049
Tbp 30.20 ± 0.70 0.161 0.001 0.160 0.322 0.089 0.375 -0.218 0.144 -0.070 -0.175 -0.252 0.077
Ppia 23.73 ± 0.10 0.214 0.221 -0.007 0.294 0.060 0.217 -0.175 0.014 -0.017 -0.142 -0.090 -0.052
Itgb1bp1 29.15 ± 0.06 0.272 0.086 0.186 0.322 -0.196 0.161 -0.029 -0.197 0.001 -0.051 0.092 -0.142
Tff3 35.70 ± 0.14 NA NA NA NA NA NA NA 0.253 0.679 NA NA 1.029
(Continued)
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even though Timp2 expression in OK and CL in Mmp2-/- and Mmp2+/- mice differ, the lim-
ited possibility of an increase in Mmp2 at the level of expression would probably reduce this
effect. This may be the reason why they are also protected. In our study, Timp1 was not
affected by UUO, and this is supported by evidence that elimination of Timp1 alone was not
found to be sufficient in order to alter the severity of fibrosis during UUO [29].
The present results did not show consistent findings in the Pdgf system. This is not entirely
surprising since the Pdgf system is important in kidney fibrosis [30] and in UUO [31,32], but it
is not necessary for the development of fibrosis in the kidney [33]. There was no differential
expression of Pdgfa or Pdgfc. On the other hand Pdgfb was differentially expressed after UUO
in Mmp2-/- and Mmp2+/+ mice but not in Mmp2+/- animals. This is difficult to explain, espe-
cially since antagonists have a positive effect in several models of renal disease. Pdgfb, however,
also plays a role in the repair of cellular damage [34].
Tff3, Vgfa, Vgfb, Vgfc, Il1b and Lgals3 were not differentially expressed in the present study
even though they have been implicated in kidney disease. Specifically, Tff3 has been suggested
as a diagnostic marker in CKD since it increases in both serum and urine during CKD progres-
sion [35]. Vegfs have been demonstrated to slow down the progression of renal injury in exper-
imental models and can be administered in renoprotective therapy [36], but overstimulation
can induce glomerular pathology. Il1b is known to stimulate proliferation of human renal
fibroblasts as well as production of matrix proteins, while Lhals3 has been shown to protect
against fibrosis [37,38].
The clinical treatment of ureteral obstruction is primarily surgical, but as a strategy for lim-
iting the destruction of kidney tissue in progressive or recurring disease, some intervention
against Mmp2 may be useful. It is further unlikely that reduced Mmp2 expression provides
complete protection from the damage in UUO. There is no doubt that a longer period of UUO
would lead to more severe damage, even in mice with decreased Mmp2 expression.
In conclusion, both homozygous and heterozygous genetic inactivation of Mmp2 protect
mice against hydronephrosis and kidney fibrosis after UUO, as indicated by both histology and
gene expression. The genetic mechanism seems to be a reduced ability to respond with Mmp2
upregulation under stress, and this may suggest that there is a threshold level of Mmp2 neces-
sary for pelvic remodelling and genetic events leading to activation of fibrosis.
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Table 2. (Continued)
Gene Average OK-/- OK-/- OK+/- OK-/- CL-/- OK+/- CL+/- OK+/+ CL+/+ Cntrl-/- Cntrl-/- Cntrl+/-
CT-value vs vs vs vs vs vs vs vs vs vs vs vs
± SEM OK+/+ OK+/- OK+/+ CL-/- Cntrl-/- CL+/- Cntrl+/- CL+/+ Cntrl+/+ Cntrl+/+ Cntrl+/- Cntrl+/+
Il1a 35.93 ± 0.31 -0.429 1.094 -1.523 1.657 -1.016 -0.533 0.624 1.242 -0.540 -0.368 0.544 -0.912
Matn1 33.92 ± 1.25 NA NA NA NA NA NA NA NA NA NA NA NA
Cntrl denotes kidneys from control animals without obstruction.
† denotes significant variations between all groups, P<0.05 by ANOVA.
* denotes P<0.05 for the individual comparison.
doi:10.1371/journal.pone.0143390.t002
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